Nitya Jain

Nitya Jain

Auto-generated profile, based on publicly available information

Nitya Jain

Mucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children, United States

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2020 in Gut Microbes
Verified
Journal Article
Open access
NJNitya Jain
Nitya Jain
The early life immune system is characterized by unique developmental milestones. Functionally diverse immune cells arise from distinct waves of hematopoietic stem cells, a phenomenon referred to as ‘layered’ immunity. This stratified development of immune cells extends to lineages of both innate and adaptive cells. The defined time window for the development of these immune cells lends itself to the influence of specific exposures typical of the early life period. The perinatal immune system develops in a relatively sterile fetal environment but emerges into one filled with a multitude of antigenic encounters. A major burden of this comes in the form of the microbiota that is being newly established at mucosal surfaces of the newborn. Accumulating evidence suggests that early life microbial exposures, including those arising in utero, can imprint long-lasting changes in the offspring’s immune system and determine disease risk throughout life. In this review, I highlight unique features of early life immunity and explore the role of intestinal bacteria in educating the developing immune system.

9 September 2014 in Nature Reviews Gastroenterology & Hepatology
Verified
Journal Article
Closed access
PDF file
NJNitya Jain
Nitya Jain
WWW. Allan Walker
W. Allan Walker

21 January 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MEMaria Ennamorati
Maria Ennamorati
CVChithirachelvi Vasudevan
Chithirachelvi Vasudevan
KCKara Clerkin
Kara Clerkin
SHStefan Halvorsen
Stefan Halvorsen
SVSmriti Verma
Smriti Verma
NJNitya Jain
Nitya Jain
The thymus generates cells of the T cell lineage that seed the lymphatic and blood systems. Transcription factor regulatory networks control the lineage programming and maturation of thymic precursor cells. Whether extrathymic antigenic events, such as the microbial colonization of the mucosal tract also shape the thymic T cell repertoire is unclear. We show here that intestinal microbes influence the thymic homeostasis of PLZF-expressing cells in early life. Impaired thymic development of PLZF+ innate lymphocytes in germ-free (GF) neonatal mice is restored by colonization with a human commensal, Bacteroides fragilis, but not with a polysaccharide A (PSA) deficient isogenic strain. Plasmacytoid dendritic cells influenced by microbes migrate from the colon to the thymus in early life to regulate PLZF+ cell homeostasis. Importantly, perturbations in thymic PLZF+ cells brought about by alterations in early gut microbiota persist into adulthood and are associated with increased susceptibility to experimental colitis. Our studies identify a pathway of communication between intestinal microbes and thymic lymphocytes in the neonatal period that can modulate host susceptibility to immune-mediated diseases later in life. Significance The burgeoning intestinal microbiota pose a unique challenge to the developing immune system of the newborn. Extensive crosstalk between mucosal immune cells and microbes is necessary to establish healthy microbial communities and promote the development of productive mucosal immunity. However, it is yet unknown whether intestinal microbes also influence the development of lymphocytes themselves in the thymus. Here, we report that thymic distribution of transcription factor PLZF-expressing innate lymphocytes is regulated by intestinal microbes in early life. Migratory plasmacytoid dendritic cells are one conveyor of microbial information to developing thymic cells and perturbation of this entero-thymic communication in early life impacts disease susceptibility in adulthood. Our data highlight a novel regulation of thymic lymphocyte development by early-life microbiota.

14 April 2003 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
AAAmit Awasthi
Amit Awasthi
RMRamkumar A Mathur
Ramkumar A Mathur
AKAslam Khan
Aslam Khan
BJBimba N. Joshi
Bimba N. Joshi
NJNitya Jain
Nitya Jain
BSBhaskar Saha
Bhaskar Saha
Leishmania, a protozoan parasite, lives and multiplies as amastigote within macrophages. It is proposed that the macrophage expressed CD40 interacts with CD40 ligand on T cells to induce IFN-γ, a Th1-type cytokine that restricts the amastigote growth. Here, we demonstrate that CD40 cross-linking early after infection resulted in inducible nitric oxide synthetase type-2 (iNOS2) induction and iNOS2-dependent amastigote elimination. Although CD40 expression remained unaltered on L. major–infected macrophages, delay in the treatment of macrophages or of mice with anti-CD40 antibody resulted in significant reduction in iNOS2 expression and leishmanicidal function suggesting impaired CD40 signaling in Leishmania infection. The inhibition of CD40-induced iNOS2 expression by SB203580, a p38-mitogen activated protein kinase (p38MAPK)-specific inhibitor, and the reversal of the inhibition by anisomycin, a p38MAPK activator, suggested a crucial role of p38MAPK in CD40 signaling. Indeed, the CD40-induced p38MAPK phosphorylation, iNOS2 expression and anti-leishmanial function were impaired in Leishmania-infected macrophages but were restored by anisomycin. Anisomycin9s effects were reversed by SB203580 emphasizing the role of p38MAPK in CD40-induced iNOS2-dependent leishmanicidal function. Anisomycin administration in L. major–infected BALB/c mice resulted in significant reduction in the parasite load and established a host-protective Th1-type memory response. Also implicated in these findings is a scientific rationale to define novel anti-parasite drug targets and to bypass the problem of drug resistance.

22 June 2022 in ImmunoHorizons
Verified
Journal Article
Open access
PDF file
JPJordan Philpott
Jordan Philpott
SKSimon Kazimierczyk
Simon Kazimierczyk
PKParimal Korgaonkar
Parimal Korgaonkar
EBEvan Bordt
Evan Bordt
JZJaclyn Zois
Jaclyn Zois
NJNitya Jain
Nitya Jain
Resident tissue macrophages (RTMs) develop from distinct waves of embryonic progenitor cells that seed tissues before birth. Tissue-specific signals drive a differentiation program that leads to the functional specialization of RTM subsets. Genetic programs that regulate the development of RTMs are incompletely understood, as are the mechanisms that enable their maintenance in adulthood. In this study, we show that the ligand-activated nuclear hormone receptor, retinoid X receptor (RXR)α, is a key regulator of murine RTM development. Deletion of RXRα in hematopoietic precursors severely curtailed RTM populations in adult tissues, including the spleen, peritoneal cavity, lung, and liver. The deficiency could be traced to the embryonic period, and mice lacking RXRα in hematopoietic lineages had greatly reduced numbers of yolk sac and fetal liver macrophages, a paucity that persisted into the immediate postnatal period.

27 November 2023 in Cell Reports Medicine
Verified
Journal Article
Open access
JPJordan D. Philpott
Jordan D. Philpott
JMJordan Miller
Jordan Miller
BBBrittany P. Boribong
Brittany P. Boribong
SCSaeina Charles
Saeina Charles
JDJameson P. Davis
Jameson P. Davis
NJNitya Jain
Nitya Jain
SARS-CoV-2 mRNA vaccines elicit humoral responses in children that are comparable to those in adults. However, early-life T cell responses are distinct from adult ones, and questions remain about the nature and kinetics of mRNA vaccine-induced T cell responses in children. We report that Pfizer BNT162b2 mRNA vaccination elicits a significant antigen-specific CD4+ T cell response in the ≥12-year-old cohort. This response is weaker in magnitude in the 5- to 11-year-old cohort and is not improved by a higher vaccine dose (Moderna mRNA1273, 100 μg), suggesting distinct developmental programming that may underscore early-life T cell immunity. Increased effector phenotypes of antigen-specific T cells in younger children correspond with elevated anti-receptor binding domain antibody levels, albeit at the cost of memory generation. These studies highlight aspects of age-specific adaptive immune responses and the need for careful consideration of priming conditions including vaccine dose and adjuvant in the pediatric population.